By Michael Millar
Date: Monday 30 Apr 2012
Consort Medical said the first product to use its built-in dose counter had been given the go-ahead by the US Food and Drug Administration.
| Margins squeezed in Dechra's Services business | 21-Feb-2012 | ShareCast |
| Whitbread chief keeps the faith | 13-Dec-2011 | ShareCast |
| Friday tips round-up: Premier Farnell, Victoria,... | 17-Jun-2011 | ShareCast |
| Healthy product pipeline for Consort Medical | 16-Jun-2011 | ShareCast |
| Tuesday tips round-up: Aggreko, Bovis, Consort M... | 15-Mar-2011 | ShareCast |
| Total Voting Rights | 01-May-2012 | 10:21 | RNS |
| FDA Approval Proprietary Integrated Dose Counter | 30-Apr-2012 | 07:00 | RNS |
| Holding(s) in Company | 20-Apr-2012 | 10:54 | RNS |
| Blocklisting Interim Review | 16-Apr-2012 | 11:37 | RNS |
| Total Voting Rights | 02-Apr-2012 | 09:29 | RNS |
| Consort's prognosis is for few surprises in its ... | 04-Nov-2008 | The Scotsman |
| Tape revamp pays off | 09-Sep-2007 | Scotland on Sunday |
| IQE boss increases stake after losses ease by 40% | 02-Apr-2006 | Scotland on Sunday |
| Device will 'transform' Bespak | 08-Jul-2004 | Guardian |
| BoE's Cooksey quits as Bespak chief | 20-Jan-2004 | Daily Mail |
| Investment Column:Consort Medical | 02-Dec-2011 | The Independent |
| Tempus:Tech Consort Medical | 25-Jun-2009 | Times |
| The Week Ahead: Lloyds and HBOS can restore some... | 10-Dec-2007 | The Independent |
| BA deal talk gets off the ground again | 19-Oct-2007 | Guardian |
| Mining stocks prop up the FTSE | 19-Jan-2007 | Guardian |
No recent information was found.
| Newspaper and magazine share tips | 02-Dec-2010 | This Is Money |
| FTSE in-depth: Hays hots up on takeover talk | 09-Sep-2010 | This Is Money |
Consort Medical PLC said the markets for its ... |
19-Mar-2009 | Proactive Investors |
| Stock market report: Thursday close | 11-Dec-2008 | This Is Money |
| Market report: Tuesday close | 24-Jun-2008 | This Is Money |
| Currency | UK Pounds |
| Share Price | 600.00p |
| Change Today | 5.00p |
| % Change | 0.84 % |
| 52 Week High | 668.00 |
| 52 Week Low | 498.00 |
| Volume | 25,378 |
| Shares Issued | 29.01m |
| Market Cap | £174.07m |
| Beta | 0.19 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 6 |
| Buy | 1 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 9 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 18-Jan-12 | 21-Sep-11 |
| Paid | 17-Feb-12 | 28-Oct-11 |
| Amount | 7.00p | 12.10p |
| Time | Volume / Share Price |
| 16:35 | 428 @ 600.00p |
| 16:22 | 74 @ 599.00p |
| 16:22 | 1,500 @ 599.00p |
| 16:22 | 1,000 @ 600.00p |
| 16:22 | 172 @ 600.50p |
| Chair | Peter Fellner |
| CEO | Jonathan Glenn |
You are here: research